Corebridge Financial, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Corebridge Financial, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.48B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $18.71B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $18.80B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $24.70B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $23.26B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $15.06B | Feb 24, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($366.00M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.23B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.10B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $8.16B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $8.24B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $642.00M | Feb 24, 2023 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.00B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.02B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.28B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.32B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.10B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $2.03B | Feb 24, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.02B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $2.15B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $3.36B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.62B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.41B | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $3.33B | Feb 24, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $413.55B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $389.40B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $379.27B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $360.32B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $416.21B | Feb 24, 2023 |
| FY2023 | Jan 1, 2021 | $422.44B | Feb 15, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $399.59B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $377.07B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $366.64B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $350.00B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $387.28B | Feb 24, 2023 |
| FY2023 | Jan 1, 2021 | $383.76B | Feb 15, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.20B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $11.46B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $11.77B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $9.38B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $27.09B | Feb 24, 2023 |
| FY2023 | Jan 1, 2021 | $36.08B | Feb 15, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $117.00M | Feb 15, 2024 |
| FY2023 | Dec 31, 2022 | $175.00M | Feb 15, 2024 |
| FY2023 | Dec 31, 2021 | $192.00M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $218.00M | Feb 24, 2023 |
| FY2022 | Dec 31, 2019 | $208.00M | Feb 24, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.37B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $19.26B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $17.57B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $18.21B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $8.86B | Feb 24, 2023 |
| FY2023 | Jan 1, 2021 | $23.77B | Feb 15, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $7.87B | Feb 24, 2023 |
| FY2022 | Dec 31, 2021 | $427.00M | Feb 24, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 13, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 13, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 496.37M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 561.49M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 621.66M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 645.00M | Feb 15, 2024 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $511.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $544.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.72B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $876.00M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $0 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $0 | Feb 24, 2023 |